Royal Bank of Canada
IDIX

Royal Bank of Canada’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Royal Bank of Canada’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-45,000
Closed -$269K – 6399
2013
Q4 		$269K Buy
+45,000
New +$208K ﹤0.01% 3926

Royal Bank of Canada's IDIX Position: Q3 2014 in Review

Royal Bank of Canada sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 2,000 shares — an estimated $48K sold.

Royal Bank of Canada first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $440K in Q1 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Royal Bank of Canada reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 2,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $48K.
  • Royal Bank of Canada first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Royal Bank of Canada's IDENIX PHARMACEUTICALS INC position peaked at $440K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Royal Bank of Canada's 13F filing for Q3 2014, filed 14 Nov 2014.